Search - tctmd.com

Displaying 481 - 500 of 3148

Sort: Relevancy | Date

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Daily News

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

L.A. McKeown

December 01, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Conference News AHA 2023

For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent

Caitlin E. Cox

November 17, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

L.A. McKeown

November 17, 2023

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Todd Neale

November 13, 2023

News Conference News AHA 2023

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Michael O'Riordan

November 12, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

Advertisement

JACC Statement Focuses on PAD Disparities, Gaps in Care

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

December 2023 Dispatch for the CV Team

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent

Mortality Risk Varies Among Patients With Very High LDL Levels

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Dapagliflozin in myocardial infarction without diabetes or heart failure

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

FDA Grants Tirzepatide a New Indication for Obesity Management

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

FDA Approves Paradise Renal Denervation System: What Comes Next?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content